
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Wellmune is a patented beta-1,3/1,6-glucan derived from baker's yeast (Saccharomyces cerevisiae) that enhances immune function by activating macrophages and natural killer cells. Clinical studies demonstrate it reduces cold incidence by 23% and decreases upper respiratory infection severity.

Reported Benefits (Provisional)
Origin & History

Wellmune is derived from the cell walls of a proprietary strain of baker's yeast. It undergoes a purification process to isolate the beta-glucan component.
Research Narrative (Provisional)
Numerous clinical trials have shown that Wellmune can enhance immune function and reduce the incidence of cold and flu symptoms.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Wellmune is a purified beta-1,3/1,6-glucan derived from the cell wall of Saccharomyces cerevisiae (baker's yeast). Primary bioactive compound: beta-glucan polysaccharide comprising approximately 75-85% of the ingredient by dry weight, with beta-1,3-glucan forming the main backbone and beta-1,6-glucan side chains responsible for immunomodulatory activity. Typical clinical doses range from 250mg to 500mg per day. Protein content is minimal, approximately 2-5% by weight, consisting of residual yeast cell wall proteins. Carbohydrate content is predominantly the beta-glucan polymer itself; free sugars are negligible (<1%). Fat content is less than 1% by weight. Fiber classification: Wellmune qualifies as a soluble dietary fiber due to its polysaccharide structure, contributing approximately 0.8-1g of fiber per 1g of ingredient. Caloric contribution is minimal, estimated at approximately 1-2 kcal per 250mg serving due to limited digestibility by human enzymes. Micronutrients: trace amounts of phosphorus and magnesium may be present from yeast cell wall residues, but concentrations are nutritionally insignificant. Bioavailability: Wellmune is not absorbed intact; instead, it is phagocytosed by macrophages in Peyer's patches of the gastrointestinal tract, then transported and sequentially broken down into smaller fragments that bind to CR3 receptors on neutrophils and natural killer cells, priming immune response. This receptor-mediated mechanism means bioactivity is high despite lack of systemic absorption. No significant interactions with fat-soluble or water-soluble vitamins have been documented.
Reported Mechanism (Provisional)
Wellmune's beta-1,3/1,6-glucan binds to complement receptor 3 (CR3/CD11b/CD18) on immune cells, primarily macrophages and neutrophils. This binding triggers downstream signaling cascades that enhance phagocytosis, cytokine production, and natural killer cell activity. The activated immune cells increase secretion of interleukin-12 and interferon-gamma, strengthening both innate and adaptive immune responses.
Clinical Narrative (Provisional)
Multiple randomized controlled trials have evaluated Wellmune's immune benefits in healthy adults and children. A 12-week study of 162 healthy adults showed 23% reduction in cold incidence and improved quality of life scores. Studies in marathon runners demonstrated reduced upper respiratory tract infection symptoms and faster recovery times. However, most trials have been relatively small (50-200 participants) and industry-sponsored, indicating need for larger independent research.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







